Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11745 | 894 | 39.4 | 64% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1046 | 9602 | OPIOID GROWTH FACTOR//OPIOID GROWTH FACTOR RECEPTOR//BETA ENDORPHIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OPIOID GROWTH FACTOR | Author keyword | 110 | 93% | 5% | 41 |
2 | OPIOID GROWTH FACTOR RECEPTOR | Author keyword | 89 | 100% | 3% | 27 |
3 | PRENATAL MORPHINE | Author keyword | 53 | 89% | 3% | 24 |
4 | MET5 ENKEPHALIN | Author keyword | 22 | 66% | 2% | 21 |
5 | LOW DOSE NALTREXONE | Author keyword | 18 | 83% | 1% | 10 |
6 | ZETA OPIOID RECEPTOR | Author keyword | 14 | 100% | 1% | 7 |
7 | PRENATAL MORPHINE EXPOSURE | Author keyword | 13 | 69% | 1% | 11 |
8 | OGFR | Author keyword | 9 | 83% | 1% | 5 |
9 | NEURAL BEHAV SCI | Address | 9 | 13% | 7% | 60 |
10 | OGF | Author keyword | 6 | 71% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OPIOID GROWTH FACTOR | 110 | 93% | 5% | 41 | Search OPIOID+GROWTH+FACTOR | Search OPIOID+GROWTH+FACTOR |
2 | OPIOID GROWTH FACTOR RECEPTOR | 89 | 100% | 3% | 27 | Search OPIOID+GROWTH+FACTOR+RECEPTOR | Search OPIOID+GROWTH+FACTOR+RECEPTOR |
3 | PRENATAL MORPHINE | 53 | 89% | 3% | 24 | Search PRENATAL+MORPHINE | Search PRENATAL+MORPHINE |
4 | MET5 ENKEPHALIN | 22 | 66% | 2% | 21 | Search MET5+ENKEPHALIN | Search MET5+ENKEPHALIN |
5 | LOW DOSE NALTREXONE | 18 | 83% | 1% | 10 | Search LOW+DOSE+NALTREXONE | Search LOW+DOSE+NALTREXONE |
6 | ZETA OPIOID RECEPTOR | 14 | 100% | 1% | 7 | Search ZETA+OPIOID+RECEPTOR | Search ZETA+OPIOID+RECEPTOR |
7 | PRENATAL MORPHINE EXPOSURE | 13 | 69% | 1% | 11 | Search PRENATAL+MORPHINE+EXPOSURE | Search PRENATAL+MORPHINE+EXPOSURE |
8 | OGFR | 9 | 83% | 1% | 5 | Search OGFR | Search OGFR |
9 | OGF | 6 | 71% | 1% | 5 | Search OGF | Search OGF |
10 | OPIOID GROWTH FACTOR OGF | 6 | 71% | 1% | 5 | Search OPIOID+GROWTH+FACTOR+OGF | Search OPIOID+GROWTH+FACTOR+OGF |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OGFR | 24 | 91% | 1% | 10 |
2 | ZETA ZETA | 21 | 78% | 2% | 14 |
3 | FACTOR RECEPTOR AXIS | 21 | 85% | 1% | 11 |
4 | OPIOID GROWTH FACTOR | 20 | 51% | 3% | 28 |
5 | FACTOR RECEPTOR OGFR | 15 | 82% | 1% | 9 |
6 | PLASMA MET ENKEPHALIN | 15 | 77% | 1% | 10 |
7 | ZETA ZETA OPIOID RECEPTOR | 14 | 100% | 1% | 7 |
8 | MODULATES BODY | 11 | 100% | 1% | 6 |
9 | FACTOR OGF | 8 | 100% | 1% | 5 |
10 | TOPICALLY APPLIED NALTREXONE | 8 | 100% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The biology of the opioid growth factor receptor (OGFr) | 2002 | 154 | 135 | 71% |
Targeting the opioid growth factor: Opioid growth factor receptor axis for treatment of human ovarian cancer | 2013 | 3 | 72 | 85% |
Opioid growth factor and the treatment of human pancreatic cancer: A review | 2014 | 1 | 39 | 90% |
Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation | 2000 | 59 | 90 | 44% |
Opioidergic regulation of astroglial/neuronal proliferation: where are we now? | 2008 | 29 | 161 | 29% |
Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: A review | 2010 | 16 | 114 | 32% |
Opioid peptides in cancer | 2004 | 21 | 92 | 40% |
Opioid growth factor modulation of corneal epithelium: Uppers and downers | 2003 | 11 | 68 | 72% |
Behavioral effects of perinatal opioid exposure | 2014 | 2 | 98 | 29% |
kappa Opioid receptor ligands regulate angiogenesis in development and in tumours | 2015 | 1 | 53 | 11% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEURAL BEHAV SCI | 9 | 13% | 6.7% | 60 |
2 | PENN LIONS VIS | 4 | 75% | 0.3% | 3 |
3 | ALBERT SZENT GYORGYI MED PHARMACEUT SCI | 3 | 28% | 1.0% | 9 |
4 | HADASSAH MED MOLEC VIROL | 1 | 100% | 0.2% | 2 |
5 | MASHHAD COGNIT NEUROSCI | 1 | 100% | 0.2% | 2 |
6 | EA DOISY BIOCHEM MOL BIOL | 1 | 12% | 0.9% | 8 |
7 | NEURAL BEHAV SCI H109 | 1 | 33% | 0.2% | 2 |
8 | CJF 93 11 | 1 | 50% | 0.1% | 1 |
9 | CNRSUNITE MIXTE RECH 5541 | 1 | 50% | 0.1% | 1 |
10 | COMPARAT MED H054 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000121271 | SEMINOL CLIN EMBRYOL//NALOXONE BINDING SITE//NURSERY 2 |
2 | 0.0000119617 | PROENKEPHALIN//PROENKEPHALINS//PRO ENKEPHALIN |
3 | 0.0000108844 | METHIONINE ENKEPHALIN//ENDOCRINE NEUROSCI NEUROIMMUNOMODULAT S//SECT MED SCI |
4 | 0.0000105624 | MU OPIOID RECEPTOR//OPIOID RECEPTOR//MOR 1 |
5 | 0.0000097881 | HYPOXIC SURVIVAL//AIRTIGHT CHAMBER//ANIMAL CAT |
6 | 0.0000075599 | DYNORPHIN//CI 977//DYNORPHIN A |
7 | 0.0000070621 | ORNITHINE DECARBOXYLASE IN DEVELOPING BRAIN//ADENYLYL CYCLASE SIGNALING//NORADRENERGIC SYSTEMS |
8 | 0.0000067654 | PHOSPHOINOSITIDE RESPONSE//DOPAMINE D 2 RECEPTOR MESSENGER RNA//EXPLANT AND PRIMARY CULTURES |
9 | 0.0000067021 | NEONATAL ABSTINENCE SYNDROME//PRENATAL COCAINE//PRENATAL COCAINE EXPOSURE |
10 | 0.0000065195 | ELECTROSHOCK SEIZURE THRESHOLD//PRODYNORPHIN MESSENGER RNA//BRAIN SITE |